What did we learn (and did not learn) from the pediatric direct oral anticoagulant trials, and how might we better design pediatric anticoagulant trials in the future?

A State of the Art lecture titled “What the direct oral anticoagulants (DOACs) trials did and didn’t tell us” was presented at the International Society on Thrombosis and Haemostasis (ISTH) Congress in 2022. The use of DOACs in children is of particular interest as they exhibit several advantages ov...

Descripción completa

Detalles Bibliográficos
Autores principales: Betensky, Marisol, Monagle, Paul, Male, Christoph, Goldenberg, Neil A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
State of the Art ISTH 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165148/
https://www.ncbi.nlm.nih.gov/pubmed/37168398
http://dx.doi.org/10.1016/j.rpth.2023.100140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165148/
https://www.ncbi.nlm.nih.gov/pubmed/37168398
http://dx.doi.org/10.1016/j.rpth.2023.100140

Ejemplares similares